Last edition
News about Consultants
Future of pharma companies communication with doctors would be hybrid model: Survey
The future of pharmaceutical companies? communication with doctors would be a hybrid model of digital communication supported by physical connect, as almost 40 per cent of the doctors prefer the model, according to a recent survey on the trends in pharma communication post Covid-19 pandemic by Rediffusion Healthcare.
Consultants | 30/11/2021 | By Darshana | 1010
Glenmark Pharmaceuticals makes it to DJSI for fourth consecutive year
Glenmark Pharmaceuticals today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI) under the category of emerging markets for the fourth consecutive year, the company notified via a statement
Consultants | 17/11/2021 | By Darshana | 611
Fidelity Health Services to expand markets globally to offer pharmacovigilance services
Besides catering to five pharmaceutical companies and a few global CROs as their outsourcing partner for pharmacovigilance services, the company has been offering its end-to-end services for the last 5 years to one of the top generic pharmaceutical companies, empowering it to market highly valued products in 30 global markets
Consultants | 01/10/2021 | By Darshana | 1055
TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid
The TB Alliance has granted Lupin a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug BPaL regimen. Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories
Consultants | 07/09/2021 | By Darshana | 676
Centrient Pharmaceuticals completes acquisition of Astral SteriTech
With the addition of Astral SteriTech's semi-synthetic cephalosporin and semi-synthetic penicillin sterile injectable finished dosage forms to Centrient's product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine
Consultants | 03/09/2021 | By Darshana | 1234
Novartis secures approval in China for Cosentyx
Novartis has announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis in paediatric patients
Consultants | 19/08/2021 | By Darshana | 655
Test At Home (TAH), backed by global VC firm Antler, is a medical technology startup, has completed clinical trial on its proprietary 'Lollipop-like' device that enables individuals to self-collect saliva sample for Covid-19 testing with around 95% accuracy based on initial clinical data
Consultants | 17/08/2021 | By Darshana | 308
Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors
Pharma major Lupin Limited (Lupin) announced today the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.
Consultants | 13/08/2020 | By Darshana | 508
Even as the number of COVID-19 cases in Maharashtra is increasing with each passing day and urgently needs remdesivir injections for critically ill patients, the Mumbai-based VJ Farma has sought no objection certificate (NOC) from Drugs Controller General of India (DCGI) for importing 5,000 remdesivir vials from a Bangladesh firm Eskayef Pharmaceuticals
Consultants | 09/07/2020 | By Darshana | 571
Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily
Thyrocare, India's leading diagnostic laboratory chain, has announced the availability of COVID Antibody Test to check your body's response to COVID-19 infection. It is not a diagnostic test, but is used for sero-surveillance to understand whether a person has encountered the infection in the recent past
Consultants | 05/07/2020 | By Darshana | 497
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy